• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人生长激素在可生物降解聚酯微球中的微囊化:蛋白质聚集稳定性和不完全释放机制

Microencapsulation of human growth hormone within biodegradable polyester microspheres: protein aggregation stability and incomplete release mechanism.

作者信息

Kim H K, Park T G

机构信息

Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Taejon, 305-701, South Korea.

出版信息

Biotechnol Bioeng. 1999 Dec 20;65(6):659-67. doi: 10.1002/(sici)1097-0290(19991220)65:6<659::aid-bit6>3.0.co;2-9.

DOI:10.1002/(sici)1097-0290(19991220)65:6<659::aid-bit6>3.0.co;2-9
PMID:10550772
Abstract

Recombinant human growth hormone (rhGH) was encapsulated within poly(D,L-lactic-co-glycolic acid) microspheres by a double emulsion solvent evaporation method. A mixture of methylene chloride and ethyl acetate in varying volume ratios was used for the microsphere preparation. Protein release profiles from three different microsphere formulations demonstrated initial burst effects ranging from 28.2% to 54.7% after a 1-day incubation and exhibited no further significant releases up to 19 days. This was because the encapsulated rhGH with the microspheres was largely aggregated in a noncovalent fashion during the formulation. Nonaggregated water soluble rhGH species within the microspheres are likely to be responsible for the rapid release upon incubation. The initially released rhGH in the incubation medium, however, was composed of mostly monomer species with a small amount of dimer as probed by size-exclusion chromatography. Circular dichroism spectra of the initially released rhGH in the medium revealed that the conformation of the released rhGH was correctly folded relative to that of native rhGH, with little variation in alpha-helix contents depending on the formulations. The "nonrelease" mechanism after the initial burst release was attributed to nonspontaneously dissociable noncovalent protein aggregation and surface adsorption of rhGH present within the microspheres.

摘要

通过复乳溶剂蒸发法将重组人生长激素(rhGH)包裹于聚(D,L-乳酸-乙醇酸)微球中。使用不同体积比的二氯甲烷和乙酸乙酯混合物制备微球。三种不同微球制剂的蛋白质释放曲线显示,孵育1天后的初始突释效应范围为28.2%至54.7%,直至19天均未出现进一步的显著释放。这是因为在制剂过程中,包裹在微球中的rhGH大部分以非共价方式聚集。微球内未聚集的水溶性rhGH物种可能是孵育时快速释放的原因。然而,通过尺寸排阻色谱法检测,孵育介质中最初释放的rhGH主要由单体物种组成,含有少量二聚体。介质中最初释放的rhGH的圆二色光谱显示,与天然rhGH相比,释放的rhGH的构象正确折叠,α-螺旋含量根据制剂不同变化不大。初始突释释放后的“非释放”机制归因于微球内rhGH的非自发解离非共价蛋白质聚集和表面吸附。

相似文献

1
Microencapsulation of human growth hormone within biodegradable polyester microspheres: protein aggregation stability and incomplete release mechanism.人生长激素在可生物降解聚酯微球中的微囊化:蛋白质聚集稳定性和不完全释放机制
Biotechnol Bioeng. 1999 Dec 20;65(6):659-67. doi: 10.1002/(sici)1097-0290(19991220)65:6<659::aid-bit6>3.0.co;2-9.
2
Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres.用于在可生物降解微球中进行微囊化的重组人生长激素和干扰素-γ的稳定制剂。
Pharm Res. 1996 Oct;13(10):1464-75. doi: 10.1023/a:1016063109373.
3
The stability of recombinant human growth hormone in poly(lactic-co-glycolic acid) (PLGA) microspheres.重组人生长激素在聚乳酸-乙醇酸共聚物(PLGA)微球中的稳定性
Pharm Res. 1997 Apr;14(4):420-5. doi: 10.1023/a:1012031012367.
4
Development of Recombinant Human Growth Hormone (rhGH) sustained-release microspheres by a low temperature aqueous phase/aqueous phase emulsion method.采用低温水相/水相乳液法制备重组人生长激素(rhGH)缓释微球。
Eur J Pharm Sci. 2014 Oct 1;62:141-7. doi: 10.1016/j.ejps.2014.05.027. Epub 2014 Jun 4.
5
Microencapsulation of dissociable human growth hormone aggregates within poly(D,L-lactic-co-glycolic acid) microparticles for sustained release.将可解离的人生长激素聚集体微囊化于聚(D,L-乳酸-乙醇酸)微粒中以实现缓释。
Int J Pharm. 2001 Oct 23;229(1-2):107-16. doi: 10.1016/s0378-5173(01)00852-3.
6
Comparative study on sustained release of human growth hormone from semi-crystalline poly(L-lactic acid) and amorphous poly(D,L-lactic-co-glycolic acid) microspheres: morphological effect on protein release.人生长激素在半结晶聚(L-乳酸)和无定形聚(D,L-乳酸-共-乙醇酸)微球中的缓释比较研究:形态对蛋白质释放的影响
J Control Release. 2004 Jul 23;98(1):115-25. doi: 10.1016/j.jconrel.2004.04.020.
7
Sustained release of etanidazole from spray dried microspheres prepared by non-halogenated solvents.依托硝唑从由非卤代溶剂制备的喷雾干燥微球中的持续释放。
J Control Release. 2002 Jun 17;81(3):263-80. doi: 10.1016/s0168-3659(02)00066-4.
8
The stabilization and encapsulation of human growth hormone into biodegradable microspheres.将人生长激素稳定化并包裹于可生物降解的微球中。
Pharm Res. 1997 Jun;14(6):730-5. doi: 10.1023/a:1012142204132.
9
Porcine insulin biodegradable polyester microspheres: stability and in vitro release characteristics.猪胰岛素可生物降解聚酯微球:稳定性及体外释放特性
Pharm Dev Technol. 2000;5(1):1-9. doi: 10.1081/pdt-100100513.
10
A novel sustained-release formulation of recombinant human growth hormone and its pharmacokinetic, pharmacodynamic and safety profiles.一种新型重组人生长激素缓释制剂及其药代动力学、药效学和安全性特征。
Mol Pharm. 2012 Jul 2;9(7):2039-48. doi: 10.1021/mp300126t. Epub 2012 Jun 13.

引用本文的文献

1
Injectable sustained-release poly(lactic-co-glycolic acid) (PLGA) microspheres of exenatide prepared by supercritical fluid extraction of emulsion process based on a design of experiment approach.基于实验设计方法,通过超临界流体萃取乳液法制备的艾塞那肽可注射缓释聚(乳酸-乙醇酸)(PLGA)微球。
Bioeng Transl Med. 2023 Jan 2;8(3):e10485. doi: 10.1002/btm2.10485. eCollection 2023 May.
2
Controlled Release of Lysozyme from Double-Walled Poly(Lactide-Co-Glycolide) (PLGA) Microspheres.溶菌酶从双层聚(丙交酯-共-乙交酯)(PLGA)微球中的控释。
Polymers (Basel). 2017 Oct 3;9(10):485. doi: 10.3390/polym9100485.
3
mPEG-PLA and PLA-PEG-PLA nanoparticles as new carriers for delivery of recombinant human Growth Hormone (rhGH).
mPEG-PLA 和 PLA-PEG-PLA 纳米粒作为新型载体用于重组人生长激素(rhGH)的递送。
Sci Rep. 2018 Jun 29;8(1):9854. doi: 10.1038/s41598-018-28092-8.
4
Poly(lactic-co-glycolic acid) devices: Production and applications for sustained protein delivery.聚乳酸-乙醇酸共聚物装置:用于持续蛋白质递送的生产与应用
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2018 Sep;10(5):e1516. doi: 10.1002/wnan.1516. Epub 2018 Mar 13.
5
Overcoming glucocorticoid resistances and improving antitumor therapies: lipid and polymers carriers.克服糖皮质激素抵抗并改善抗肿瘤治疗:脂质和聚合物载体
Pharm Res. 2015 Mar;32(3):968-85. doi: 10.1007/s11095-014-1510-4. Epub 2014 Sep 12.
6
Developments in human growth hormone preparations: sustained-release, prolonged half-life, novel injection devices, and alternative delivery routes.人增长激素制剂的发展:缓释、延长半衰期、新型注射装置和替代给药途径。
Int J Nanomedicine. 2014 Jul 25;9:3527-38. doi: 10.2147/IJN.S63507. eCollection 2014.
7
Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies.克服生物制药给药方面的挑战:制剂与递送策略。
Nat Rev Drug Discov. 2014 Sep;13(9):655-72. doi: 10.1038/nrd4363. Epub 2014 Aug 8.
8
An Approach to the Design of a Particulate System for Oral Protein Delivery .II. Preparation and Stability Study of rhGH-Loaded Microspheres in Simulated Gastrointestinal Fluids.一种用于口服蛋白质递送的微粒系统的设计方法。II. 重组人生长激素负载微球在模拟胃肠液中的制备及稳定性研究
Iran J Pharm Res. 2011 Spring;10(2):183-92.
9
Light-activated, in situ forming gel for sustained suprachoroidal delivery of bevacizumab.光激活、原位形成凝胶用于持续眼上腔递送贝伐单抗。
Mol Pharm. 2013 Aug 5;10(8):2858-67. doi: 10.1021/mp300716t. Epub 2013 Jul 8.
10
Glycosylation improves α-chymotrypsin stability upon encapsulation in poly(lactic-co-glycolic)acid microspheres.糖基化作用在α-胰凝乳蛋白酶被包裹于聚乳酸-乙醇酸共聚物微球中时可提高其稳定性。
Results Pharma Sci. 2012;2:46-51. doi: 10.1016/j.rinphs.2012.08.001.